Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/11727
Title: Function and expression of ATIP and its variants in cardiomyoblast cell line H9c2.
Austin Authors: Varghayee, Naghmeh;Krezel, Michael A;Rezmann, Linda Adriana;Chow, Laurie T C;Frauman, Albert G ;Louis, William J ;Louis, Simon N S
Affiliation: Clinical Pharmacology and Therapeutics Unit, Department of Medicine, University of Melbourne, Austin Health, Australia
Issue Date: 4-Apr-2013
Publication information: Journal of the Renin-angiotensin-aldosterone System : Jraas 2013; 16(1): 79-91
Abstract: Cardiac hypertrophy in myocytes is in part regulated by changes in expression of a novel Ang II type 2 receptor (AT2-receptor) interacting protein identified as ATIP.The role of the AT2-receptor in cardiac hypertrophy is controversial, with some reports indicating that AT2-receptor activation has detrimental effects on disease progression, whereas others indicate that it has a beneficial role.In an effort to unravel this paradox, we examined the expression and function of ATIP in cell-based models of cardiac hypertrophy using QPCR, immunohistochemistry, cell proliferation, morphological and transfection techniques in H9c2 cardio-myoblast and myotubules.These studies indicate that in cultured cardio-myoblast and myotubules, Ang II mediates cellular hypertrophy and proliferation solely via the AT1-receptor, the ATIP variants are abundantly expressed and that ATIP3 may play an anti-proliferative/hypertrophic role in these cells in the absence of AT2-receptor expression or activation.Previously ATIP has been shown to inhibit growth factor signalling in cancerous cells via an interaction with the AT2-receptor. This is the first report to identify that ATIP may have a similar role in other disease states characterised by excessive growth and indicates that for ATIP3, at least, an interaction with the AT2-receptor may not be necessary.
Gov't Doc #: 23559668
URI: http://ahro.austin.org.au/austinjspui/handle/1/11727
DOI: 10.1177/1470320313483845
URL: https://pubmed.ncbi.nlm.nih.gov/23559668
Type: Journal Article
Subjects: ATIP
Angiotensin II
ERK phosphorylation
angiotensin II type 2 receptor
cardiac hypertrophy
Appears in Collections:Journal articles

Show full item record

Page view(s)

12
checked on Dec 2, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.